Search - tctmd.com

Presenter: Peter Smits, A. J. van Boven, Mariano Valdes, Antonio Serra, Jean-Jacques Goy, V. Voudris, Ramiro Trillo, J. M. Vazquez, Peter den Heijer, Ton Slagboom, A.G. Vuillomenet

January 31, 2013

Presentation TCT 2013

A Prospective Randomized Multi-center Trial to Assess the Everolimus-Eluting Stent System (Promus Element) for Coronary Revascularization in a Population of Unrestricted Patients

Presenter: Jean Fajadet, Eulogio Garcia, David Hildick-Smith, Sonia Petronio, Sigmund Silber, Franz-Josef Neumann, Azfar Zaman, Jochen W?hrle, Mark Spence, simon elhadad

January 31, 2013

News Daily News

EES Outperform First-Generation DES in Treatment of CTOs

L.A. McKeown

December 27, 2012

News Daily News

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Caitlin E. Cox

December 26, 2012

News Daily News

Equivalencia en el Mundo Real Confirmada de los Stents liberadores de Zotarolimus y Everolimus

Caitlin E. Cox

December 26, 2012

News Industry News

First Patient Enrolled in the Boston Scientific Multicenter Study of the SYNERGY™ Coronary Stent System Featuring a Bioabsorbable Polymer Coating

November 29, 2012

Advertisement

Clinical, Angiographic and IVUS Outcomes of the NG PROMUS Clinical Trial Evaluating the Novel Promus PREMIER Stent

For Bifurcation Lesions in Coronary Arteries, Medtronic's Resolute Stent Delivers Strong Long-Term Results

Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

NEXT Published: Biodegradable Polymer BES Shows Noninferiority to EES

NEXT Publicado: Los SLB de Polímero Biodegradable No son Inferiores a los SLE

PLATINUM China Trial Demonstrates Positive Outcomes for The Boston Scientific PROMUS Element™ Stent

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

Three-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents

Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES

Pair of Studies Show Positive Stent Results at ACC

Underpowered Study Finds Differences Between CABG, PCI in Diabetics

Un Estudio No dotado de las Herramientas necesarias Halla Diferencias entre la CABG y la PCI en Diabéticos

Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval

Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...

A Prospective Randomized Multi-center Trial to Assess the Everolimus-Eluting Stent System (Promus Element) for Coronary Revascularization in a Population of Unrestricted Patients

EES Outperform First-Generation DES in Treatment of CTOs

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Equivalencia en el Mundo Real Confirmada de los Stents liberadores de Zotarolimus y Everolimus

First Patient Enrolled in the Boston Scientific Multicenter Study of the SYNERGY™ Coronary Stent System Featuring a Bioabsorbable Polymer Coating

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content